The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance

Hillel Yaffe Medical Center40 enrolled

Overview

The aim of this study is to evaluate the insulin-like growth factor (IGF) axis involvement in the immune tumor microenvironment in ovarian cancer.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Ovarian Cancer

Interventions

BiopsyOTHER

Biopsy taken during surgical procedure

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women diagnosed with epithelium ovarian cancer who have undergone surgery Exclusion Criteria: * Pregnant women

Locations (1)

Hillel Yaffe Medical Center

Hadera, Israel

Outcomes

Primary Outcomes

Involvement of IGF Axis in Ovarian Cancer

Ovarian cancer specimens taken during surgical procedures will be evaluated and analyzed by flow cytometry assays to determine the involvement of the IGF axis in the immune tumor microenvironment in ovarian cancer

Time frame: Two years

Central Contacts

Hagit Stolz, DVM

CONTACT

972-4-7744335 hagitst@hy.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.